financetom
Business
financetom
/
Business
/
Exclusive-AstraZeneca pauses $270 million investment in Britain
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Exclusive-AstraZeneca pauses $270 million investment in Britain
Sep 12, 2025 10:06 AM

LONDON (Reuters) - Britain's biggest company AstraZeneca ( AZN ) has paused a planned 200 million pound ($271.26 million) investment in its Cambridge research site, a spokesperson said, the latest drugmaker to retreat from Britain.

The decision on the investment, which had been set to create 1,000 jobs, means none of AstraZeneca's ( AZN ) planned new funding - originally announced in March 2024 - is currently proceeding.

In January, the company scrapped plans to invest 450 million pounds in its vaccine manufacturing plant in northern England, citing a cut in British government support.

U.S. drugmaker Merck & Co ( MRK ) this week blamed the UK's challenging business environment as it abandoned a new research centre in London.

Asked about speculation over its pharmaceutical investments following the Merck ( MRK ) announcement, a spokesperson for AstraZeneca ( AZN ), which has the biggest market capitalisation on the FTSE 100, confirmed it would pause its investment plans in Cambridge, where it has one of Britain's leading life sciences hubs.

"We constantly reassess the investment needs of our company and can confirm our expansion in Cambridge is paused. We have no further comment to make," an AstraZeneca ( AZN ) spokesperson said.

The news, which will come as a blow to Prime Minister Keir Starmer's government and its efforts to draw investment into the UK's stagnant economy, comes just days before U.S. President Donald Trump arrives in Britain for a state visit.

AstraZeneca ( AZN ) in July said it would spend $50 billion to expand manufacturing and research capabilities in the United States by 2030 - one of many announcements by pharmaceutical companies reacting to Trump's tariff policy.

Trump has criticised Britain and Europe for not paying high enough prices for drugs, and several pharmaceutical firms have criticised Britain for what they say is long-term undervaluation of medicines and innovation.

After AstraZeneca ( AZN ) dropped its vaccine plant investment plan, Chief Executive Pascal Soriot urged Britain to improve the environment for businesses in order to drive investment.

($1 = 0.7373 pounds)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
T-Mobile US, KKR to Form JV to Buy Fiber Company Metronet
T-Mobile US, KKR to Form JV to Buy Fiber Company Metronet
Jul 24, 2024
03:26 PM EDT, 07/24/2024 (MT Newswires) -- T-Mobile US ( TMUS ) said Wednesday it agreed to form a joint venture with investment firm KKR (KKR) that will acquire fiber company Metronet, as the wireless carrier looks to expand its broadband portfolio. T-Mobile expects to invest roughly $4.9 billion at closing to acquire a 50% equity interest in the joint...
Spreading Canadian wildfires prompt more evacuation warnings, oil production worries
Spreading Canadian wildfires prompt more evacuation warnings, oil production worries
Jul 24, 2024
July 24 (Reuters) - Hundreds of uncontrolled wildfires burned across western Canada on Wednesday, putting more communities under evacuation alert and raising concerns about the blazes impacting Canadian crude production. There are 430 active wildfires in British Columbia and 177 active wildfires in Alberta, including more than a dozen in the Fort McMurray region, Canada's key oil sands hub. This...
Lockheed Martin Shares Climb On Positive Analyst Ratings And Strong Q2 Results
Lockheed Martin Shares Climb On Positive Analyst Ratings And Strong Q2 Results
Jul 24, 2024
Lockheed Martin Corporation ( LMT ) shares are higher Wednesday after multiple analysts raised their price targets following the company’s second-quarter earnings. What Happened: The aerospace and defense giant reported earnings per share (EPS) of $7.11 for Q2 2024, surpassing analysts’ expectations of $6.46. Additionally, revenue for the quarter reached $18.122 billion, exceeding the anticipated $17.044 billion. Earnings Highlight Revenue...
--Starwood Property Trust Keeps Quarterly Dividend at $0.48 Per Share, Payable on Oct. 15 to Shareholders on Sept. 30
--Starwood Property Trust Keeps Quarterly Dividend at $0.48 Per Share, Payable on Oct. 15 to Shareholders on Sept. 30
Jul 24, 2024
03:28 PM EDT, 07/24/2024 (MT Newswires) -- Price: 19.76, Change: -0.76, Percent Change: -3.68 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved